Sign up to save your podcasts
Or
Share A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
129 Listeners
Global News Podcast
7,899 Listeners
Neurology® Podcast
273 Listeners
NEJM This Week
313 Listeners
Practical Neurology Podcast
35 Listeners
JAMA Clinical Reviews
488 Listeners
JAMA Neurology Author Interviews
13 Listeners
Annals On Call Podcast
169 Listeners
The Clinical Problem Solvers
506 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
317 Listeners
Neurology Exam Prep Podcast
176 Listeners
The Curious Clinicians
365 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
75 Listeners